Skip to main content

Wealthspire Advisors, LLC

SEC CIK
0001646247
Latest filing
Aug 11, 2026

SPRY holding history

ARS Pharmaceuticals, Inc. in every 13F filed by Wealthspire Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2025
Holdings of SPRY by Wealthspire Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−23,650−100.0%Sold outHolders
Q4 202523,650$275.5K<0.1%+23,650NewHolders